Abstract
Cocaine (benzoylmethylecgonine, C17H21NO4), a natural alkaloid, is derived from Erythroxylon coca, a plant indigenous to parts of South America, Mexico, the West Indies, and Indonesia. It is a pharmacologically diverse drug with local anesthetic, central nervous system stimulant, and sympathomimetic properties. As a readily available herb, it has been used and abused for over 5,000 years. Initially ingested by the Andean people to treat high-altitude fatigue in South America, it had application also as a topical local anesthetic, for spinal anesthesia, and as a dilator of the pupil for cataract surgery [1]. In 1914, the Harrison Narcotic Act limited its medical use in the United States. Over the past 20 years, the abuse of cocaine has grown enormously because of ubiquitous availability and reduction in cost (When adjusted for inflation, cocaine is now approximately 20% of the 1980s street price) [2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Katzung BG. Drugs of abuse, Basic and clinical pharmacology. 10th ed. New York, NY: McGraw-Hill companies; 2007. p. 518–23.
Borden D. Editorial “Yes, the drug war really is still failing, DEA and ONDCP”. http://stopthedrugwar.org/chronicle/504/yes_the_drug_war_really_is_failing. Accessed 11 Apr 2010.
US Department of Health and Human Services. National survey on drug use and health. Washington DC: US Department of Health and Human Services; 2008. Figures 2.1, 2.6.
Brookoff D, Campbell EA, Shaw LM. The underreporting of cocaine-related trauma: drug abuse warning network reports vs hospital toxicology tests. Am J Public Health. 1993;83(3):369–71.
Feinstein L, Schmidt K. Cocaine users present unique anesthetic challenges: part 1. Anesthesiol News. 2010;36-2:8–9.
Pendergrast M. For god, country, and coca-cola. New York, NY: Charles Scribner’s Sons; 1993. p. 32–3. 90–91, 355–56.
Hertting G, Axelrod J, Whitby LG. Effect of drugs on the uptake and metabolism of H3-norepinephrine. J Pharmacol Exp Ther. 1961;134:146–53.
Jatlow PI. Drug of abuse profile: cocaine. Clin Chem. 1987;33:66B–71.
Bernards CM, Artru A, Visco E, et al. Chronic cocaine exposure alters carbon dioxide reactivity but does not affect cerebral blood flow autoregulation in anesthetized dogs. J Trauma. 2002;52:912–21.
Lange RA, Hillis LD. Cardiovascular complications in cocaine use. N Engl J Med. 2001;345(5):351–8.
Hollander JE, Hoffman RS. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med. 1992;10:169–77.
Meisels IS, Loke J. The pulmonary effects of free-base cocaine: a review. Cleve Clin J Med. 1993;60:325–9.
Jatlow P, Barash PG, Van Dyke C, et al. Cocaine and succinylcholine sensitivity: a new caution. Anesth Analg. 1979;58:235–8.
Chestnut DH. Substance abuse. In: Obstetric anesthesia: principle and practice, 3rd ed. New York, NY: Elsevier Mosby; 2004.
O’Brien CP. Drug addiction and drug abuse. In: Hardman JG, Limbird LE, editors. The pharmacological basis of therapeutics. New York, NY: McGraw-Hill; 2002. p. 621–42.
Ndikum-Moffor FM, Schoeb TR, Roberts SM. Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine. J Pharmacol Exp Ther. 1998;248:413–9.
Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend. 2003;72:169–82.
Wang Z, Fermini B, Nattel S. Mechanism of flecainide’s rate-dependent actions on action potential duration in canine atrial tissue. J Pharmacol Exp Ther. 1993;267:575–81.
Bauman JL, Grawe JJ, Winecoff AP, Hariman RJ. Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations. J Clin Pharmacol. 1994;34:902–11.
Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol. 2007;100(6):1040–3.
Lucena J, Blanco M, Jurado C, Rico A, Salguero M, Vazquez R, et al. Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur Heart J. 2010;31(3):318–29. Epub 2010 Jan 12.
Kimura S, Bassett AL, Xi H, Myerburg RJ. Early after-depolarizations and triggered activity induced by cocaine. Circulation. 1992;85:2227–35.
DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004;23:223–38.
Charbit B, Samain E, Merckx P, Funck-Brentano C. QT interval measurement. Anesthesiology. 2006;104:255–60.
Khan IA, Long QT. Syndrome: diagnosis and management. Am Heart J. 2002;143:7–14.
Chvilicek JP, Hurlbert BJ, Hill GE. Diuretic-induced hypokalaemia inducing torsades de pointes. Can J Anaesth. 1995;42:1137–9.
Solaini L, Gourgiotis S, Salemis NS, Koukis I. Bilateral pneumothorax, lung cavitations, and pleural empyema in a cocaine addict. Gen Thorac Cardiovasc Surg. 2008;56(12):610–2.
Averbach M, Casey KK, Frank E. Near-fatal status asthmaticus induced by nasal insufflation of cocaine. South Med J. 1996;89(3):340–1.
Gotway MB, Marder SR, Hanks DK, Leung JW, Dawn SK, Gean AD, et al. Thoracic complications of illicit drug use: an organ system approach. Radiographics. 2002;22:S119–35.
Restrepo CS, Carrillo JA, Martínez S, Ojeda P, Rivera AL, Hatta A. Pulmonary complications from cocaine and cocaine-based substances: imaging manifestations. Radiographics. 2007;27(4):941–56.
Herrine SK, Park PK, Wechsler RJ. Acute mesenteric ischemia following intranasal cocaine use. Dig Dis Sci. 1998;43(3):586–9.
Lingamfelter DC, Knight LD. Sudden death from massive gastrointestinal hemorrhage associated with crack cocaine use: case report and review of the literature. Am J Forensic Med Pathol. 2010;31(1):98–9.
Nalbandian H, Sheth N, Dietrich R, Georgiou J. Intestinal ischemia caused by cocaine ingestion: report of two cases. Surgery. 1985;97(3):374–6.
Abramson DL, Gertler JP, Lewis T, Kral JG. Crack-related perforated gastropyloric ulcer. J Clin Gastroenterol. 1991;13(1):17–9.
Johnson BA, Dawes MA, Roache JD, Wells LT, Ait-Daoud N, Mauldin JB, et al. Acute intravenous low- and high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder. J Cereb Blood Flow Metab. 2005;25(7):928–36.
Levine SR, Brust JC, Futrell N, Ho KL, Blake D, Millikan CH, et al. Cerebrovascular complications of the use of the “crack” form of alkaloidal cocaine. N Engl J Med. 1990;323(11):699–704.
Petty GW, Brust JC, Tatemichi TK, Barr ML. Embolic stroke after smoking “crack” cocaine. Stroke. 1990;21(11):1632–5.
MacEwen C, Ward M, Buchan A. A case of cocaine-induced basilar artery thrombosis. Nat Clin Pract Neurol. 2008;4(11):622–6.
Dhuna A, Pascual-Leone A, Langendorf F, Anderson DC. Epileptogenic properties of cocaine in humans. Neurotoxicology. 1991;12(3):621–6.
Daras M, Koppel BS, Atos-Radzion E. Cocaine-induced choreoathetoid movements (‘crack dancing’). Neurology. 1994;44(4):751–2.
Heesch CM, Negus BH, Steiner M, et al. Effects of in vivo cocaine administration on human platelet aggregation. Am J Cardiol. 1996;78:237–9.
Kugelmass AD, Oda A, Monahan K, Cabral C, Ware JA. Activation of human platelets by cocaine. Circulation. 1993;88(3):876–83.
Kuckowski KM, Birnbach DJ, Van Zunder A. Drug abuse in the parturient. Semin Anesth Perioperat Med Pain. 2000;19:216–24.
Birnbach DJ, Stein DJ. The substance-abusing parturient: implications for analgesia and anesthesia management. Baillieres Clin Obstet Gynaecol. 1998;12:443–60.
Kuckowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:382–94.
Kuckowski KM. The cocaine abusing parturient: a review of anesthetic considerations. Can J Anaesth. 2004;51(2):145–54.
Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med. 1995;333:1267–72.
Hill GE, Ogunnaike BO, Johnson ER. General anaesthesia for the cocaine abusing patient: is it safe? Br J Anaesth. 2006;97:654–7.
Susskind H, Weber DA, Volkow ND, Hitzemann R. Increased lung permeability following long-term use of free-base cocaine (crack). Chest. 1991;100:903–9.
Baldwin GC, Choi R, Roth MD, et al. Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal (“crack”) cocaine. Chest. 2002;121:1231–8.
Norris KC, Thornhill-Joynes M, Robinson C, et al. Cocaine use, hypertension, and end-stage renal disease. Am J Kidney Dis. 2001;38:523–8.
Hoffman RS. Cocaine and beta-blockers: should the controversy continue? Ann Emerg Med. 2008;51(2):127–9. Epub 2007 Sep 24.
McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117:1897–907.
Battaglia G, Napier TC. The effects of cocaine and the amphetamines on brain and behavior: a conference report. Drug Alcohol Depend. 1998;52:41–8.
Moreno AY, Janda KD. Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence. Pharmacol Biochem Behav. 2009;92(2):199–205.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kaye, A.D., Weinkauf, J.L. (2012). The Cocaine-Addicted Patient. In: Bryson, E., Frost, E. (eds) Perioperative Addiction. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0170-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0170-4_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0169-8
Online ISBN: 978-1-4614-0170-4
eBook Packages: MedicineMedicine (R0)